ARTICLE https://harbor-dev.pubfactory.com/view/journals/jnccn/13/1/article-p1.xml Meet the New JNCCN! 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/13/1/article-p2.xml After Local Therapy for Esophageal Cancer, Should We Continue to Survey Patients and, If So, Why and How? 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/13/1/article-p7.xml The Birth of NCCN 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/13/1/article-p9.xml Cotreatment of Hairy Cell Leukemia and Melanoma With the BRAF Inhibitor Dabrafenib 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/13/1/article-p19.xml Identification of a Novel Fusion Gene, IRF2BP2-RARA, in Acute Promyelocytic Leukemia 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/13/1/article-p23.xml Lung Cancer Screening, Version 1.2015 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/13/1/article-p41.xml Effect of Hepatitis C Virus Infection in Patients With Cancer: Addressing a Neglected Population 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/13/1/article-p51.xml Predictors of Guideline Treatment Nonadherence and the Impact on Survival in Patients With Colorectal Cancer 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/13/1/article-p61.xml Cost Implications and Complications of Overtreatment of Low-Risk Prostate Cancer in the United States 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/13/1/article-p69.xml Guideline Familiarity Predicts Variation in Self-Reported Use of Routine Surveillance PET/CT by Physicians Who Treat Head and Neck Cancer 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/13/1/article-p78.xml Neuroendocrine Tumors, Version 1.2015 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/13/1/article-p109.xml Role of Somatostatin Analogues in the Treatment of Neuroendocrine Tumors 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/13/1/article-p118.xml Paving the Road to Clinical Trial Participation: Removing Road Blocks and Directing Patients Toward Novel Therapies 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/13/1/article-pe1.xml Management of Chemotherapy-Induced Neutropenia: Measuring Quality, Cost, and Value 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/13/1/article-pxiv.xml NCCN News 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/13/1/article-pxxiv.xml Oncology Research Program 2019-01-04